Healio (2/14, Gramigna) reports, “The Patient Health Questionnaire-9 [PHQ-9] appeared reliable and valid for depression screening among patients with neurological disorders,” researchers concluded after analyzing “PHQ-9 questionnaire responses from 277 patients admitted to a neurology department at Peking University,” then using “the Mini-International Neuropsychiatric Interview…and Hamilton Rating Scale for Depression to assess depressive symptoms.” The findings were published online Feb. 9 in BMC Psychiatry.
Related Links:
— “PHQ-9 may offer effective depression screening in patients with neurological disorders “Joe Gramigna, Healio, February 14, 2022